Amide N-glucuronidation of maxipost catalyzed by UDP- glucuronosyltransferase 2B7 in humans

Drug Metabolism and Disposition

Volumn 32, Issue 5, 2004, Pages 545-551

  Zhang, Donglu ^a   Zhao, Weiping ^a   Roongta, Vikram A ^a   Mitroka, James G ^a   Klunk, Lewis J ^a   Zhu, Mingshe ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (5 CHLORO 2 METHOXYPHENYL) 3 FLUORO 2,3 DIHYDRO 6 TRIFLUOROMETHYL 1H INDOL 2 ONE; GLUCURONOSYLTRANSFERASE;

ARTICLE; BILE; CATALYSIS; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME DEGRADATION; ESCHERICHIA COLI; FRAGMENTATION REACTION; GLUCURONIDATION; HUMAN; MICHAELIS CONSTANT; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; URINALYSIS;

AMIDES; ANIMALS; CATALYSIS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG STABILITY; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; INDOLES; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; POTASSIUM CHANNELS, CALCIUM-ACTIVATED;

CANIS FAMILIARIS; ESCHERICHIA COLI; HELIX POMATIA;

EID: 2042474751     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.32.5.545     Document Type: Article

References (40)

1. Babu SR, Lakshmi VM, Hsu FF, Zenser TV, and Davis BB (1992) Role of N-glucuronidation in benzidine-induced bladder cancer in dog. Carcinogenesis 13:1235-1240.
2. Barbier O, Turgeon D, Girard C, Green MD, Tephly TR, Hum DW, and Belanger A (2000) 3′-Azido-3′-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7). Drug Metab Dispos 28:497-502.
3. Bridges JW, Kibby MR, Walker SR, and Williams RT (1961) Species differences in the metabolism of surphadimethoxine. Biochem J 109:851-856.
4. Chang CP, Dworetzky SI, Wang J, and Goldstein ME (1997) Differential expression of the a and b subunits of large-conductance calcium-activated potassium channel: implication for channel diversity. Mol Brain Res 45:33-40.
5. Cheney JA, Weisser JD, Bareyre FM, Laurer HL, Saatman KE, Raghupathi R, Gribkoff VK, Starrett JE Jr, and McIntosh TK (2001) The maxi-K channel opener BMS-204352 attenuates regional cerebral edema and neurologic motor impairment after experimental brain injury. J Cereb Blood Flow Metab 21:396-403.
6. Coffman BL, Kearney WR, Green MD, Lowery RG, and Tephly TR (2001) Analysis of opioid binding to UDP-glucuronosyltransferase 2B7 fusion proteins using nuclear magnetic resonance spectroscopy. Mol Pharmacol 59:1464-1469.
7. Coffman BL, Rios GR, King CD, and Tephly TR (1997) Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1-4.
8. Czernik PJ, Little JM, Barone GW, Raufman J, and Radominska-Pandya A (2000) Glucuronidation of estrogens and retinoic acid and expression of UDP-glucuronosyl transferase 2B7 in human intestinal mucosa. Drug Metab Dispos 28:1210-1216.
9. 3H labeled (S)-3-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl) -2H-indol-2-one, Maxipost™, an agent for post-stroke neuroprotection. J Labelled Compd Radiopharm 46:139-149.
10. Dulik DM and Fenselau C (1987) Species-dependent glucuronidation of drugs by immobilized rabbits, rhesus monkeys and human UDP-glucuronyltransferases. Drug Metab Dispos 15:473-477.
11. Ethell BT, Riedel J, Englert H, Jantz H, Oekonomopulos R, and Burchell B (2003) Glucuronidation of HMR1098 in human microsomes: evidence for the involvement of UGT1A1 in the formation of S-glucuronides. Drug Metab Dispos 31:1027-1034.
12. Fisher MB, Campanale B, Ackermann BL, Vandenbranden M, and Wrighton SA (2000) In vitro glucuronidation using human microsomes and the pore-forming peptide alamethicin. Drug Metab Dispos 28:560-566.
13. Ghosheh O and Hawes EM (2002) N-Glucuronidation of nicotine and cotinine in human: formation of continine glucuronide in liver microsomes and lack of catalysis by 10 examined UDP-glucuronosyltransferases. Drug Metab Dispos 30:991-996.
14. Green MD and Tephly TR (1998) Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins. Drug Metab Dispos 26:860-867.
15. Gribkoff VK, Starrett Jr JE, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Herman K, Hibbard JR, Huston K, et al. (2001) Targeting acute ischemic stroke with a calcium sensitive opener of Maxi-K potassium channels. Nat Med 7:471-477.
16. Gruenke LD, Craig JC, Wester RC, Maibach HI, Howard I, North-Root H, and Corbin NC (1987) A selected ion monitoring GC/MS assay for 3,4,4′- trichlorocarbaniline and its metabolites in biological fluids. J Anal Toxicol 11:75-85.
17. Hewawasam P, Gribkoff VK, Pendri Y, Dworetzky SI, Meanwell NA, Martinez E, Boissard CG, Post-Munson DJ, Trojnacki JT, Yeleswaram K, et al. (2002) The synthesis and characterization of BMS-204352 and related 3-fluorooxindoles as openers of Maxi-K potassium channels. Bioorg Med Chem Lett 12:1023-1026.
18. Holthe M, Klepstad P, Zahlsen K, Borchgrevink PC, Dale O, Kaasa S, Krokan HE, and Skorpen F (2002) Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy. Eur J Clin Pharmacol 58:353-356.
19. Holthe M, Rakvag TN, Klepstad P, Idle JR, Kaasa S, Krokan HE, and Skorpen F (2003) Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients. Pharmacogenomics J 3:17-26.
20. Howe JL, Back DJ, and Colbert J (1992) Extrahepatic metabolism of zidovudine. Br J Clin Pharmacol 33:190-192.
21. Innocenti F, Iyer L, Ramirez J, Green MD, and Ratain MJ (2001) Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. Drug Metab Dispos 29:686-692.
22. Jin C, Miners JO, Lillywhite KJ, and Mackenzie PI (1993) Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J Pharmacol Exp Ther 264:475-479.
23. Kadlubar FF, Miller JA, and Miller EC (1997) Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. Cancer Res 37:805-814.
24. Kiesewetter DO, Jagoda EM, Starrett JE Jr, Gribkoff VK, Hewawasam P, Srinivas NR, Salazar D, and Eckelman WC (2002) Radiochemical synthesis and biodistribution of a novel maxi-K potassium channel opener. Nucl Med Biol 29:55-59.
25. King CD, Rios GR, Assouline JA, and Tephly TR (1999) Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in human brain and identification of 5-hydroxytryptamine as a substrate. Arch Biochem Biophy 365:156-162.
26. King CD, Rios GR, Green MD, and Tephly TR (2000) UDP- glucuronosyltransferases. Curr Drug Metab 1:143-161.
27. King CD, Tang W, Ngui J, Tephly T, and Braun M (2001) Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac. Toxicol Sci 61:49-53.
28. Kowalczyk I, Hawes EM, and McKay G (2000) Stability and enzymatic hydrolysis of quaternary ammonium-linked glucuronide metabolites of drugs with an aliphatic tertiary amine-implications for analysis. J Pharm Biomed Anal 22:803-811.
29. Krishna R, Yao M, Srinivas NR, Shah V, Pursley JM, Arnold M, and Vachharajani NN (2002) Disposition of radiolabeled BMS-204352 in rats and dogs. Biopharm Drug Dispos 23:41-46.
30. Lynn RK, Smith RG, Thompson RM, Deinzer ML, Griffin D, and Gerrber N (1978) Characterization of glucuronide metabolites of carbamazepine in human urine by gas chromatography and mass spectrometry. Drug Metab Dispos 6:494-501.
31. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Belanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, et al. (1997) The UDP-glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenomics 7:255-269.
32. Martin IJ, Lewis RJ, Bonnert RV, Cage P, and Moody GC (2003) NMR identification of an S-linked glucuronide of a triazole thione formed in vitro. Drug Metab Dispos 31:694-696.
33. Miners JO and Mackenzie PI (1991) Drug glucuronidation in humans. Pharmacol Ther 51:347-369.
34. Munzel PA, Schmohl S, Heel H, Kalberer K, Bock-Hennig BS, and Bock KW (1999) Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9 and UGT2B7 by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells. Drug Metab Dispos 27:569-573.
35. Pacifici GM, Evangelisti L, Giuliani L, Metelli RM, and Giorani R (1996) Zidovudine glucuronidation in human liver: interindividual variability. Int J Clin Pharmacol Ther 34:329-334.
36. Rios GR and Tephly TR (2002) Inhibition and active sites of UDP-glucuronosyltransferases 2B7 and 1A1. Drug Metab Dispos 30:1364-1367.
37. Smith JN and Williams RT (1949) The fate of aniline in rabbit. Biochem J 44:242-250.
38. Williams GR, Jiang JG, Atchar DB, and Samsa GP (1999) Incidence and occurrence of total (first-ever and recurrent) strokes. Stroke 30:2523-2528.
39. Zhang DL, Ogan M, Gedamke R, Roongta V, Dai R, Zhu M, Rinehart K, Klunk L, and Mitroka J (2003a) Protein covalent binding of MaxiPost through a P450-mediated ortho-quinone methide intermediate in rats. Drug Metab Dispos 31:837-845.
40. Zhang JY, Zhan J, Cook CS, Ings RM, and Breau AP (2003b) Involvement of human UGT 2B7 and 2B15 in rofecoxib metabolism. Drug Metab Dispos 31:652-658.